Navigation Links
Medicare Approves in Home Sleep Apnea Testing
Date:4/8/2008

Insurance Companies Expected To Match Medicare Policy

SAN CARLOS, Calif., April 8, 2008 /PRNewswire/ -- The Centers for Medicare and Medicaid Services (CMS) have approved at-home sleep testing for obstructive sleep apnea (OSA). Previous policy had mandated that suspected sleep apnea sufferers undergo facility-based polysomnography. The new policy allows continuous positive airway pressure (CPAP) treatment for Medicare patients who are diagnosed via unattended home monitoring devices. This decision will likely prompt increased coverage from insurance companies around the country.

"SleepQuest is very excited about the change in coverage as it demonstrates that our portable sleep testing program, which we have successfully offered for the past 14 years, is a viable and effective alternative to sleep lab testing," said Robert Koenigsberg, SleepQuest President. "Dr. William Dement, SleepQuest's Chief Scientific Advisor and I applaud CMS's in-depth analysis of this topic, providing greater access and allowing the many sufferers of OSA to benefit from treatment."

While coverage has been approved, providers of in-home sleep testing are still waiting to hear the specific date that the policy will actually go into effect. However, several insurance providers have already begun to align their coverage with Medicare.

"We were quite happy to learn that upon hearing of the approval, Aetna immediately revised their medical policy to mirror Medicare's," said Lori Schulman, SleepQuest's Director of Contracting. "We expect other plans that follow Medicare, such as Triwest, will also adopt this policy. SleepQuest has also been in contact with insurance providers, such as Blue Cross of California, who currently allow home sleep testing but impose coverage restrictions."

SleepQuest will continue to work closely with Medicare and insurance companies to ensure that coverage expands, making treatment more available and affordable to more patients. An estimated 30 million Americans suffer from some form of sleep apnea.

SleepQuest has been a leader in at-home testing and treatment of sleep apnea for more than 14 years. With Medicare's official approval, they anticipate significant growth and expansion. A new San Francisco office is scheduled to open by July.

"We anticipate that as coverage continues expanding, we will be able to focus on getting more patients tested quickly and comfortably in the home environment," said Koenigsberg. "We look forward to helping even more OSA sufferers with our comprehensive approach to wellness and vitality."


'/>"/>
SOURCE SleepQuest
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. STAAR Surgicals Collamer(R) IOL Designated as a New Technology Intraocular Lens by the Centers for Medicare and Medicaid Services
2. MedicareCRM(TM) to Speak at IIR Medicare Advantage Congress
3. Medicare Coverage Recommended for In-Home Sleep Testing
4. House and Senate Pass Medicare Legislation to Freeze 2008 Reimbursement for Therapeutic Radiopharmaceuticals at 2007 Levels
5. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
6. QMed, Inc. Reports July Medicare SNP Enrollments
7. 3SBio Inc. Approves Share Repurchase Program
8. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
9. FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder
10. FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy
11. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2017)... -- The Alliance for Safe Biologic Medicines (ASBM) today issued ... guidance on biologic naming: We commend ... importance of distinct naming for all biologics, including biosimilars. ... will bring to patients, including new treatment options and ... the Guidance dealing with suffix design remains at odds ...
(Date:1/13/2017)... , Jan 13, 2017 Research and Markets ... report to their offering. ... The global biopolymers market to grow at a CAGR of 16.83% during ... and the growth prospects of the global biopolymers market for 2017-2021. To ... sale of sales of biopolymer products. The report also includes a a ...
(Date:1/13/2017)... ... 13, 2017 , ... FireflySci has been busy rolling out ... diverse customer base. The latest entry in this field is a series of ... Bio-Rad. FireflySci is introducing three distinct varieties including a 10x1mm, 10x2 and 10x4 ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... VTI, Vertebral Technologies, Inc., announces the successful outcome of the first lumbar ... 2016, VTI (Vertebral Technologies, Inc.) has partnered with Mexico-based medical product company ...
Breaking Biology Technology:
(Date:12/15/2016)... 2016  There is much more to innovative access ... engine. Continental will demonstrate the intelligence of today,s solutions ... . Through the combination of the keyless entry and ... elements, the international technology company is opening up new ... "The integration of biometric elements brings our ...
(Date:12/8/2016)...  Singulex, Inc., the leader in Next Generation Immunodiagnostics ... license and supply agreement with Thermo Fisher Scientific, the ... access to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker ... to diagnose systemic bacterial infection and sepsis and in ... in assessing the risk of critically ill patients for ...
(Date:12/7/2016)... , Dec. 7, 2016   Veridium ... announced the appointment of new CEO James ... executive with decades of experience, has served in ... Cisco, where he specialized in expanding a pipeline ... technology portfolios. He most recently served as managing ...
Breaking Biology News(10 mins):